LS
Life Sciences Angel Network
Angel InvestorActiveLife Sciences Angel Network provides early-stage life science companies with operational, mentorship and financial support.
11
Investments
2
Exits
—
AUM
18.2%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Life Sciences Angel Network.
Investment Thesis & Strategy
Life Sciences Angel Network invests in early-stage life science companies, as well as fintech and SaaS companies, providing them with financial and operational support.
Investment Activity
Deals per year over the last 5 years
2
20181
20192
20202
20211
2022Portfolio Companies
Selected investments from their portfolio of 11 companies
L
Laronde
Biotech · Series B, 2022
V
VaxForm
Biotech · Series A, 2021
L
Laronde
Biotech · Series A, 2021
A
Aegle Therapeutics
Biotech · Series A, 2020
I
InnoLife
Healthcare · Series A, 2020
V
VaxForm
Biotech · Seed, 2019
A
Aegle Therapeutics
Biotech · Seed, 2018
I
InnoLife
Healthcare · Seed, 2018
Frequently Asked Questions
Life Sciences Angel Network focuses on Pre-seed, Seed stage investments.